A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not curing the cancer,

An experimental drug nearly doubles survival for some pancreatic cancer patients, offering hope with fewer side effects than chemotherapy.

"These results will change how scientists, clinicians, and patients think about treatment for pancreatic cancer," said Dr. Brian Wolpin of Harvard's ​Dana-Farber Cancer Institute and principal investi...